Loading…

Emerging mechanisms progress of colorectal cancer liver metastasis

Colorectal cancer (CRC) is the third most common malignancy and the second most common cause of cancer-related mortality worldwide. A total of 20% of CRC patients present with distant metastasis. The hepatic portal venous system, responsible for collecting most intestinal blood, makes the liver the...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in endocrinology (Lausanne) 2022-12, Vol.13, p.1081585-1081585
Main Authors: Zhao, Wenhu, Dai, Shipeng, Yue, Lei, Xu, Fan, Gu, Jian, Dai, Xinzheng, Qian, Xiaofeng
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c468t-6b2732510fde2c1a67e8da3529cf07484f07b680450a8e9f3fd4c935a5d76e883
cites cdi_FETCH-LOGICAL-c468t-6b2732510fde2c1a67e8da3529cf07484f07b680450a8e9f3fd4c935a5d76e883
container_end_page 1081585
container_issue
container_start_page 1081585
container_title Frontiers in endocrinology (Lausanne)
container_volume 13
creator Zhao, Wenhu
Dai, Shipeng
Yue, Lei
Xu, Fan
Gu, Jian
Dai, Xinzheng
Qian, Xiaofeng
description Colorectal cancer (CRC) is the third most common malignancy and the second most common cause of cancer-related mortality worldwide. A total of 20% of CRC patients present with distant metastasis. The hepatic portal venous system, responsible for collecting most intestinal blood, makes the liver the most common site of CRC metastasis. The formation of liver metastases from colorectal cancer is a long and complex process. It involves the maintenance of primary tumors, vasculature invasion, distant colonization, and metastasis formation. In this review, we serve on how the CRC cells acquire stemness, invade the vascular, and colonize the liver. In addition, we highlight how the resident cells of the liver and immune cells interact with CRC cells. We also discuss the current immunotherapy approaches and challenges we face, and finally, we look forward to finding new therapeutic targets based on novel sequencing technologies.
doi_str_mv 10.3389/fendo.2022.1081585
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_0b847b9a91ce4f9f9ce19c00163eb35b</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_0b847b9a91ce4f9f9ce19c00163eb35b</doaj_id><sourcerecordid>2758355791</sourcerecordid><originalsourceid>FETCH-LOGICAL-c468t-6b2732510fde2c1a67e8da3529cf07484f07b680450a8e9f3fd4c935a5d76e883</originalsourceid><addsrcrecordid>eNpVkUtLxDAQgIMoKrp_wIP06GXXvB8XQcUXLHjRc0jTSY20zZp0Bf-91V1FwzAZkpkvgQ-hE4IXjGlzHmBo0oJiShcEayK02EGHREo-p8zQ3T_1AZqV8oqnxTExRu-jAyaF1ISoQ3R100Nu49BWPfgXN8TSl2qVU5uhlCqFyqcuZfCj6yrvBg-56uL7lHsYXZkilmO0F1xXYLbdj9Dz7c3T9f18-Xj3cH25nHsu9TiXNVWMCoJDA9QTJxXoxjFBjQ9Ycc2nXEuNucBOgwksNNwbJpxolASt2RF62HCb5F7tKsfe5Q-bXLTfBym31uUx-g4srjVXtXGGeODBBOOBGI8xkQxqJuqJdbFhrdZ1D42HYcyu-wf9fzPEF9umd2uUolyICXC2BeT0toYy2j4WD13nBkjrYqkSmgmhDJla6abV51RKhvD7DMH2y6X9dmm_XNqty2no9O8Hf0d-zLFP3LKcRw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2758355791</pqid></control><display><type>article</type><title>Emerging mechanisms progress of colorectal cancer liver metastasis</title><source>PubMed Central</source><creator>Zhao, Wenhu ; Dai, Shipeng ; Yue, Lei ; Xu, Fan ; Gu, Jian ; Dai, Xinzheng ; Qian, Xiaofeng</creator><creatorcontrib>Zhao, Wenhu ; Dai, Shipeng ; Yue, Lei ; Xu, Fan ; Gu, Jian ; Dai, Xinzheng ; Qian, Xiaofeng</creatorcontrib><description>Colorectal cancer (CRC) is the third most common malignancy and the second most common cause of cancer-related mortality worldwide. A total of 20% of CRC patients present with distant metastasis. The hepatic portal venous system, responsible for collecting most intestinal blood, makes the liver the most common site of CRC metastasis. The formation of liver metastases from colorectal cancer is a long and complex process. It involves the maintenance of primary tumors, vasculature invasion, distant colonization, and metastasis formation. In this review, we serve on how the CRC cells acquire stemness, invade the vascular, and colonize the liver. In addition, we highlight how the resident cells of the liver and immune cells interact with CRC cells. We also discuss the current immunotherapy approaches and challenges we face, and finally, we look forward to finding new therapeutic targets based on novel sequencing technologies.</description><identifier>ISSN: 1664-2392</identifier><identifier>EISSN: 1664-2392</identifier><identifier>DOI: 10.3389/fendo.2022.1081585</identifier><identifier>PMID: 36568117</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>cancer stem cells ; colorectal cancer ; Colorectal Neoplasms - pathology ; Colorectal Neoplasms - therapy ; EMT ; Endocrinology ; Humans ; liver metastasis ; Liver Neoplasms ; tumor micro environment</subject><ispartof>Frontiers in endocrinology (Lausanne), 2022-12, Vol.13, p.1081585-1081585</ispartof><rights>Copyright © 2022 Zhao, Dai, Yue, Xu, Gu, Dai and Qian.</rights><rights>Copyright © 2022 Zhao, Dai, Yue, Xu, Gu, Dai and Qian 2022 Zhao, Dai, Yue, Xu, Gu, Dai and Qian</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c468t-6b2732510fde2c1a67e8da3529cf07484f07b680450a8e9f3fd4c935a5d76e883</citedby><cites>FETCH-LOGICAL-c468t-6b2732510fde2c1a67e8da3529cf07484f07b680450a8e9f3fd4c935a5d76e883</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772455/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772455/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36568117$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhao, Wenhu</creatorcontrib><creatorcontrib>Dai, Shipeng</creatorcontrib><creatorcontrib>Yue, Lei</creatorcontrib><creatorcontrib>Xu, Fan</creatorcontrib><creatorcontrib>Gu, Jian</creatorcontrib><creatorcontrib>Dai, Xinzheng</creatorcontrib><creatorcontrib>Qian, Xiaofeng</creatorcontrib><title>Emerging mechanisms progress of colorectal cancer liver metastasis</title><title>Frontiers in endocrinology (Lausanne)</title><addtitle>Front Endocrinol (Lausanne)</addtitle><description>Colorectal cancer (CRC) is the third most common malignancy and the second most common cause of cancer-related mortality worldwide. A total of 20% of CRC patients present with distant metastasis. The hepatic portal venous system, responsible for collecting most intestinal blood, makes the liver the most common site of CRC metastasis. The formation of liver metastases from colorectal cancer is a long and complex process. It involves the maintenance of primary tumors, vasculature invasion, distant colonization, and metastasis formation. In this review, we serve on how the CRC cells acquire stemness, invade the vascular, and colonize the liver. In addition, we highlight how the resident cells of the liver and immune cells interact with CRC cells. We also discuss the current immunotherapy approaches and challenges we face, and finally, we look forward to finding new therapeutic targets based on novel sequencing technologies.</description><subject>cancer stem cells</subject><subject>colorectal cancer</subject><subject>Colorectal Neoplasms - pathology</subject><subject>Colorectal Neoplasms - therapy</subject><subject>EMT</subject><subject>Endocrinology</subject><subject>Humans</subject><subject>liver metastasis</subject><subject>Liver Neoplasms</subject><subject>tumor micro environment</subject><issn>1664-2392</issn><issn>1664-2392</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkUtLxDAQgIMoKrp_wIP06GXXvB8XQcUXLHjRc0jTSY20zZp0Bf-91V1FwzAZkpkvgQ-hE4IXjGlzHmBo0oJiShcEayK02EGHREo-p8zQ3T_1AZqV8oqnxTExRu-jAyaF1ISoQ3R100Nu49BWPfgXN8TSl2qVU5uhlCqFyqcuZfCj6yrvBg-56uL7lHsYXZkilmO0F1xXYLbdj9Dz7c3T9f18-Xj3cH25nHsu9TiXNVWMCoJDA9QTJxXoxjFBjQ9Ycc2nXEuNucBOgwksNNwbJpxolASt2RF62HCb5F7tKsfe5Q-bXLTfBym31uUx-g4srjVXtXGGeODBBOOBGI8xkQxqJuqJdbFhrdZ1D42HYcyu-wf9fzPEF9umd2uUolyICXC2BeT0toYy2j4WD13nBkjrYqkSmgmhDJla6abV51RKhvD7DMH2y6X9dmm_XNqty2no9O8Hf0d-zLFP3LKcRw</recordid><startdate>20221208</startdate><enddate>20221208</enddate><creator>Zhao, Wenhu</creator><creator>Dai, Shipeng</creator><creator>Yue, Lei</creator><creator>Xu, Fan</creator><creator>Gu, Jian</creator><creator>Dai, Xinzheng</creator><creator>Qian, Xiaofeng</creator><general>Frontiers Media S.A</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20221208</creationdate><title>Emerging mechanisms progress of colorectal cancer liver metastasis</title><author>Zhao, Wenhu ; Dai, Shipeng ; Yue, Lei ; Xu, Fan ; Gu, Jian ; Dai, Xinzheng ; Qian, Xiaofeng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c468t-6b2732510fde2c1a67e8da3529cf07484f07b680450a8e9f3fd4c935a5d76e883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>cancer stem cells</topic><topic>colorectal cancer</topic><topic>Colorectal Neoplasms - pathology</topic><topic>Colorectal Neoplasms - therapy</topic><topic>EMT</topic><topic>Endocrinology</topic><topic>Humans</topic><topic>liver metastasis</topic><topic>Liver Neoplasms</topic><topic>tumor micro environment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhao, Wenhu</creatorcontrib><creatorcontrib>Dai, Shipeng</creatorcontrib><creatorcontrib>Yue, Lei</creatorcontrib><creatorcontrib>Xu, Fan</creatorcontrib><creatorcontrib>Gu, Jian</creatorcontrib><creatorcontrib>Dai, Xinzheng</creatorcontrib><creatorcontrib>Qian, Xiaofeng</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in endocrinology (Lausanne)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhao, Wenhu</au><au>Dai, Shipeng</au><au>Yue, Lei</au><au>Xu, Fan</au><au>Gu, Jian</au><au>Dai, Xinzheng</au><au>Qian, Xiaofeng</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Emerging mechanisms progress of colorectal cancer liver metastasis</atitle><jtitle>Frontiers in endocrinology (Lausanne)</jtitle><addtitle>Front Endocrinol (Lausanne)</addtitle><date>2022-12-08</date><risdate>2022</risdate><volume>13</volume><spage>1081585</spage><epage>1081585</epage><pages>1081585-1081585</pages><issn>1664-2392</issn><eissn>1664-2392</eissn><abstract>Colorectal cancer (CRC) is the third most common malignancy and the second most common cause of cancer-related mortality worldwide. A total of 20% of CRC patients present with distant metastasis. The hepatic portal venous system, responsible for collecting most intestinal blood, makes the liver the most common site of CRC metastasis. The formation of liver metastases from colorectal cancer is a long and complex process. It involves the maintenance of primary tumors, vasculature invasion, distant colonization, and metastasis formation. In this review, we serve on how the CRC cells acquire stemness, invade the vascular, and colonize the liver. In addition, we highlight how the resident cells of the liver and immune cells interact with CRC cells. We also discuss the current immunotherapy approaches and challenges we face, and finally, we look forward to finding new therapeutic targets based on novel sequencing technologies.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>36568117</pmid><doi>10.3389/fendo.2022.1081585</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1664-2392
ispartof Frontiers in endocrinology (Lausanne), 2022-12, Vol.13, p.1081585-1081585
issn 1664-2392
1664-2392
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_0b847b9a91ce4f9f9ce19c00163eb35b
source PubMed Central
subjects cancer stem cells
colorectal cancer
Colorectal Neoplasms - pathology
Colorectal Neoplasms - therapy
EMT
Endocrinology
Humans
liver metastasis
Liver Neoplasms
tumor micro environment
title Emerging mechanisms progress of colorectal cancer liver metastasis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T15%3A25%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Emerging%20mechanisms%20progress%20of%20colorectal%20cancer%20liver%20metastasis&rft.jtitle=Frontiers%20in%20endocrinology%20(Lausanne)&rft.au=Zhao,%20Wenhu&rft.date=2022-12-08&rft.volume=13&rft.spage=1081585&rft.epage=1081585&rft.pages=1081585-1081585&rft.issn=1664-2392&rft.eissn=1664-2392&rft_id=info:doi/10.3389/fendo.2022.1081585&rft_dat=%3Cproquest_doaj_%3E2758355791%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c468t-6b2732510fde2c1a67e8da3529cf07484f07b680450a8e9f3fd4c935a5d76e883%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2758355791&rft_id=info:pmid/36568117&rfr_iscdi=true